Director, HTA & Value for Obesity Early Pipeline

Pfizer; New York (NY); Hybrid; USD 177,000 - 294,000; Full time

Benefits offered by this job

Hybrid work model

Relocation assistance may be available

Job summary

Pfizer is seeking a Director, HTA, Value & Evidence (HV&E) for Internal Medicine Early Pipeline in the US. You will shape HEOR strategy, oversee real-world evidence studies, and guide cost-effectiveness and budget impact analyses to optimize patient access for obesity and non-obesity products.

You will lead cross-functional teams, coordinate inputs from country offices, and drive evidence generation, dissemination, and partnerships to support early development and launch readiness.

Qualifications

• Graduate degree in a health or related field.
• 7+ years of HEOR or 5+ years in HEOR with MSc/ MPH/ MBA; PhD/ DrPH preferred.

Responsibilities

• Provide strategic input into trial designs and analysis for payer and regulatory decision-making.
• Lead development of evidence generation strategy for obesity and non-obesity assets in the Internal Medicine portfolio.
• Coordinate input from local country/regional teams to support global market access at launch and lifecycle.
• Design and execute global HEOR studies and economic models from concept to publication.
• Develop PRO strategy and incorporate humanistic/economic endpoints across trials.
• Disseminate HEOR materials per regulatory guidance and SOPs; engage stakeholders.
• Develop partnerships with external experts, payers, and academic/community settings.

Skills

Leadership

Cross-functional collaboration

Project management

English communication

Strategic thinking

Stakeholder engagement

Execution mindset

Education

Graduate degree (MSc/ MPH/ PhD)

7+ years HEOR or 5+ years related fields with MSc/ MPH/ MBA

Job description

Pfizer is seeking a Director, HTA, Value & Evidence (HV&E) for Internal Medicine Early Pipeline in the US. You will shape HEOR strategy, oversee real-world evidence studies, and guide cost-effectiveness and budget impact analyses to optimize patient access for obesity and non-obesity products.

You will lead cross-functional teams, coordinate inputs from country offices, and drive evidence generation, dissemination, and partnerships to support early development and launch readiness.